E. Healy et al., UP-REGULATION OF P21(WAF1 CIP1) IN PSORIASIS AND AFTER THE APPLICATION OF IRRITANTS AND TAPE STRIPPING/, Journal of investigative dermatology, 105(2), 1995, pp. 274-279
p21(WAF1/CIP1) is a nucleoprotein that was initially characterized by
its ability to be regulated transcriptionally by p53 and by its abilit
y to mediate growth arrest by binding to cyclin-dependent kinases. Alt
hough p21(WAF1/CIP1) is thought to mediate the effects of p53 in causi
ng growth arrest, p21(WAF1/CIP1) is, also regulated in a p53-independe
nt manner, e.g., during terminal differentiation of some cell lines. G
rowth factors including epidermal growth factor also induce p21(WAF1/C
IP1) through p53-independent pathways. Because the epidermal growth fa
ctor signaling pathway is abnormal in psoriatic epidermis, we studied
p21(WAF1/CIP1) expression, using in situ hybridization and immunohisto
chemistry, in psoriasis. Both p21(WAF1/CIP1) mRNA and protein were sig
nificantly elevated in untreated psoriatic plaques compared with uninv
olved psoriatic skin (p < 0.0001), with the up-regulation of p21(WAF1/
CIP1) being predominantly suprabasal. This increase was accompanied by
a small increase in p53 protein expression of uncertain significance.
Furthermore, p21(WAF1/CIP1) expression was induced in skin after sell
otape stripping and by the application of agents, such as dithranol, t
hat are capable of inducing hyperproliferation. The pattern of p21(WAF
1/CIP1) expression observed is consistent with a role in induction and
maintenance of differentiation. Our experiments, however, cannot dete
rmine whether the abnormalities of p21(WAF1/CIP1) epidermal expression
in psoriasis and after insult are independent of changes in p53 expre
ssion.